Phase II study of antineoplastons A10 and AS2-1 in children with rhabdoid tumor of the central nervous system.
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications CNS cancer; Rhabdoid tumour
- Focus Therapeutic Use
- 17 Jan 2017 Status changed from active, no longer recruiting to discontinued.
- 21 Jul 2009 Additional lead trial centre (NCI) identified as reported by ClinicalTrials.gov.
- 21 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.